Back to Search
Start Over
Healthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012.
- Source :
-
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2018 Aug; Vol. 23 (32). - Publication Year :
- 2018
-
Abstract
- An aim of the ECDC point prevalence survey (PPS) in European Union/European Economic Area acute care hospitals was to acquire standardised healthcare-associated infections (HAI) data. We analysed one of the most common HAIs in the ECDC PPS, healthcare-associated pneumonia (HAP). Standardised HAI case definitions were provided and countries were advised to recruit nationally representative subsets of hospitals. We calculated 95% confidence intervals (CIs) around prevalence estimates and adjusted for clustering at hospital level. Of 231,459 patients in the survey, 2,902 (1.3%; 95% CI: 1.2-1.3) fulfilled the case definition for a HAP. HAPs were most frequent in intensive care units (8.1%; 95% CI: 7.4-8.9) and among patients intubated on the day of the survey (15%; 95% CI: 14-17; n = 737 with HAP). The most frequently reported microorganism was Pseudomonas aeruginosa (17% of 1,403 isolates), followed by Staphylococcus aure us (12%) and Klebsiella spp. (12%). Antimicrobial resistance was common among isolated microorganisms. The most frequently prescribed antimicrobial group was penicillins, including combinations with beta-lactamase inhibitors. HAPs occur regularly among intubated and non-intubated patients, with marked differences between medical specialities. HAPs remain a priority for preventive interventions, including surveillance. Our data provide a reference for future prevalence of HAPs at various settings.
- Subjects :
- Adolescent
Adult
Aged
Aged, 80 and over
Anti-Infective Agents therapeutic use
Child
Child, Preschool
Cross Infection drug therapy
Cross Infection microbiology
Europe epidemiology
European Union
Female
Gram-Negative Bacteria drug effects
Gram-Positive Bacteria drug effects
Healthcare-Associated Pneumonia drug therapy
Healthcare-Associated Pneumonia microbiology
Humans
Infant
Infant, Newborn
Inpatients
Intensive Care Units
Klebsiella drug effects
Klebsiella isolation & purification
Length of Stay statistics & numerical data
Male
Middle Aged
Pseudomonas aeruginosa drug effects
Pseudomonas aeruginosa isolation & purification
Staphylococcus aureus drug effects
Staphylococcus aureus isolation & purification
Young Adult
Anti-Bacterial Agents therapeutic use
Cross Infection epidemiology
Gram-Negative Bacteria isolation & purification
Gram-Positive Bacteria isolation & purification
Healthcare-Associated Pneumonia epidemiology
Subjects
Details
- Language :
- English
- ISSN :
- 1560-7917
- Volume :
- 23
- Issue :
- 32
- Database :
- MEDLINE
- Journal :
- Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
- Publication Type :
- Academic Journal
- Accession number :
- 30107871
- Full Text :
- https://doi.org/10.2807/1560-7917.ES.2018.23.32.1700843